Abstract
Cancer is the most common malignant tumor of the endocrine glands and comprises 1% of all malignant cancers and its incidence is still increasing. No comprehensive study summarizing the results of these studies was found. Therefore, this study aimed to determine the prevalence of thyroid cancer in Iran in a systematic review and meta-analysis. In this review, studies were extracted by searching the national and international databases of SID, MagIran, IranMedex, IranDoc, and Google Scholar, Cochrane, Embase, ScienceDirect, Scopus, PubMed, and Web of Science (WoS) from 1997 to September 2019. Simple random effects model was used for data analysis and heterogeneity of studies was investigated with I2 index. Data were analyzed using Comprehensive Meta-Analysis (version 2) software. In 28 reviewed articles, the prevalence of thyroid cancer in Iran was reported to be 3.5% with a sample size of 100,869 (95% CI: 2.7–4.4%). Regarding heterogeneity on the basis of meta-regression, there was no significant difference between the effect of the year of study (P = 0.531) and sample size (P = 0.864) and the prevalence of thyroid cancer in Iran. The results of this study indicated that the prevalence of thyroid cancer is high in Iran. Therefore, appropriate strategies should be put in place by providing feedback to hospitals in order to improve the aforementioned situation, and troubleshoot and monitor at all levels.
Similar content being viewed by others
Availability of Data and Materials
Datasets are available through the corresponding author upon reasonable request.
Abbreviations
- SID:
-
Scientific Information Database
- STROBE:
-
Strengthening the Reporting of Observational Studies in Epidemiology for cross-sectional Study
- PRISMA:
-
Preferred Reporting Items for Systematic Reviews and Meta-Analysis
References
Livolsi VA (2011) Papillary thyroid carcinoma: an update. Mod Pathol 24:1–9
Schweppe RE (2012) Thyroid cancer cell lines: critical models to study thyroid cancer biology and new therapeutic targets. Front Endocrinol 3:81
Li M, Milas M, Nasr C, Brainard JA, Khan MJ, Burkey BB, Scharpf J (2013) Anaplastic thyroid cancer in young patients: a contemporary review. Am J Otolaryngol 34(6):636–640
Hundahl SA, Fleming ID, Fremgen AM, Menck HR (1998) A National Cancer Data Base report on 53,856 cases of thyroid carcinoma treated in the US, 1985–1995. Cancer: Interdisciplinary International Journal of the American Cancer Society 83(12):2638–2648
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC (2011) Anaplastic thyroid cancer: a review of epidemiology, pathogenesis, and treatment. J Oncol 2011:542358
Deandrea M, Gallone G, Veglio M, Balsamo A, Grassi A, Sapelli S, Rossi C, Nasi R, Porcellana V, Varvello G (1997) Thyroid cancer histotype changes as observed in a major general hospital in a 21-year period. J Endocrinol Invest 20(2):52–58
Reynolds P, Elkin EP, Layefsky ME, Lee GM (1999) Cancer in California school employees, 1988–1992. Am J Ind Med 36(2):271–278
Coard K (1997) The pathology of thyroid neoplasms at the University Hospital of the West Indies. A 10-year analysis. The West Indian medical journal 46(3):80–82
Verkooijen HM, Fioretta G, Pache J-C, Franceschi S, Raymond L, Schubert H, Bouchardy C (2003) Diagnostic changes as a reason for the increase in papillary thyroid cancer incidence in Geneva. Switzerland Cancer Causes & Control 14(1):13–17
Bacher-Stier C, Riccabona G, Tötsch M, Kemmler G, Oberaigner W, Moncayo R (1997) Incidence and clinical characteristics of thyroid carcinoma after iodine prophylaxis in an endemic goiter country. Thyroid 7(5):733–741
Haghpanah V, Soliemanpour B, Heshmat R, Mosavi-Jarrahi AR, Tavangar SM, Malekzadeh R, Larijani B (2006) Endocrine cancer in Iran: based on cancer registry system. Indian J Cancer 43(2):80–85
Larijani B, Aghakhani S, Khajeh-Dini H, Baradar-Jalili R (2003) Clinico-pathological features of thyroid cancer as observed in five referral hospitals in Iran. Acta Oncol 42(4):334–337
Ries LAG, Melbert D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, et al (2007) SEER Cancer Statistics Review, 1975-2004, National Cancer Institute. Bethesda, MD. https://seer.cancer.gov/csr/1975_2004/, based on November 2006 SEER data submission, posted to the SEER web site
Kohler BA, Ward E, McCarthy BJ et al (2011) Annual report to the nation on the status of cancer, 1975–2007, featuring tumors of the brain and other nervous system. J Natl Cancer Inst 103:714
Chen AY, Jemal A, Ward EM (2009) Increasing incidence of differentiated thyroid cancer in the United States, 1988–2005. Cancer: Interdisciplinary International Journal of the American Cancer Society 115(16):3801–3807
Enewold L, Zhu K, Ron E, Marrogi AJ, Stojadinovic A, Peoples GE, Devesa SS (2009) Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980–2005. Cancer Epidemiology and Prevention Biomarkers 18(3):784–791
Khoshnevis N, Ahmadizar F, Alizadeh M, Akbari ME (2012) Nutritional assessment of cancer patients in Tehran, Iran. Asian Pac J Cancer Prev 13(4):1621–1626
Vandenbroucke JP, VON Elm E, Altman DG, Gotzsche PC, Mulrow CD, Pocock SJ et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explantion and elaboration. Epidemiology 18(6):805–35
Moayeri H, Oloomi Z, Sambo SA (2011) A cross-sectional study to determine the prevalence of calcium metabolic disorder in malignant childhood cancers in patients admitted to the pediatric ward of Vali-Asr Hospital. Acta Medica Iranica 49(12):818–823
Safavi A, Azizi F, Jafari R, Chaibakhsh S, Safavi AA (2016) Thyroid cancer epidemiology in Iran: a time trend study. Asian Pac J Cancer Prev 17(1):407–412
Zekoi SR, Mousavi Z, Rezaei H, Mehrabi M (2006) Prevalence of benign and malignant thyroid masses following childhood head and neck radiotherapy in Khorasan province, Iranian Journal of Endocrinology and Metabolism, Shahid Beheshti University of Medical Sciences. Year 4(3):161–164
Shahbazi D, Azar DA (2004) Prevalence of radiation-related cancers in Chaharmahal va Bakhtiari province over a 5 year period. Shahrekord Medical University the period 6(1):7–13
Mohaghegh F, Hamta A, Shariatzadeh SMA (2006) Survey of common cancers in Markazi province and their system of registration in 2001–2005 years compared to national statistics, Arak University of Medical Sciences Journal. Eleventh year, Number 2:84–93
Shahesmaeili A, Malekpour Afshar R, Sadeghi A, Bazrafshan A (2018) Cancer incidence in Kerman Province, Southeast of Iran: report of an ongoing population-based cancer registry, 2014. Asian Pac J Cancer Prev 19(6):1533–1541
Roshani Z, Kamrani AAA, Shati M, Sahaf R (2016) Prevalence of types of cancers in the elderly covered by insurance of the Islamic Republic of Iran Broadcasting Company in 2015 - Comparison with younger groups. Asian Pac J Cancer Prev 17:269–273
Javanmardi M (1997) Thyroid carcinoma in patients with goiter treated by surgery at Kashan Naghavi Hospital Year 1983- 1989, Kashan University of Medical Sciences and Health Services. 1(2):55–60
Talaeizadeh AH, Sarmast MH (2005) Prevalence and type of malignancy in thyroid nodules in patients referred to Imam Khomeini Hospital in Ahvaz Year 1991-2000, Ahvaz University of Medical Sciences. 10(38):87–93
Hajivandi A, Mohammadi A, Aezadi A (2005) Ultrasound prevalence of thyroid nodules in people aged 15–65 referred to Fatemeh Zahra Hospital in Bushehr Year 2005. Bushehr University of Medical Science 11:87–94
Haghpanah V, Solaimanpour B, Heshmat R, Tavangar S M. (2006). Endocrine cancers in four provinces of Iran, Journal of Sabzevar School of Medical Sciences. the period. 13(4): 190–195.
Ahmadi A, Salehi F, Ahmadimirghaed Z (2018) Cancer trends in a province of Southwest of Iran, 2003–2016. Journal of Research in Medical Sciences 23(1):80–89
Salim EI, Moore MA, Bener A, Habib OS, Seif-Eldin I, Sobue T (2010) Cancer epidemiology in South-West Asia-past, present and future. Asian Pac J Cancer Prev 11(Suppl 2):33–48
Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N (2013) Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000–2010. Hematol Oncol Stem Cell Ther 6(2):58–64
Larijani B, Mohagheghi MA, Bastanhagh MH, Mosavi-Jarrahi AR, Haghpanah V, Tavangar SM, Bandarian F, Khaleghian N (2005) Primary thyroid malignancies in Tehran. Iran Medical principles and practice 14(6):396–400
Acknowledgements
The authors thank the Student Research Committee, Kermanshah University of Medical Sciences.
Funding
By deputy of research and technology, Kermanshah University of Medical Sciences (980794). The deputy of research and technology, Kermanshah University of Medical Sciences, had no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript.
Author information
Authors and Affiliations
Contributions
MK and NS contributed to the design and MM to statistical analysis and participated in most of the study steps. MK and MM prepared the manuscript. MK and MM assisted in designing the study, and helped in the interpretation of the study. All authors have read and approved the content of the manuscript.
Corresponding author
Ethics declarations
Ethics Approval and Consent to Participate
Ethics approval was received from the Ethics Committee of deputy of research and technology, Kermanshah University of Medical Sciences. Reference Number: IR.KUMS.REC.1398.856.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Salari, N., Kazeminia, M. & Mohammadi, M. The Prevalence of Thyroid Cancer in Iran: a Systematic Review and Meta-analysis. Indian J Surg Oncol 13, 225–234 (2022). https://doi.org/10.1007/s13193-021-01465-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13193-021-01465-8